GLP-1 therapy isnt right for everyone, but for the right candidates, it can be life-changing
Dunham is among people who have struggled with their weight to turn to semaglutide, which was originally developed for diabetes and sold as Ozempic, but was approved for weight loss by the FDA in 2021 under the name Wegovy
This hormone helps regulate appetite, insulin secretion, and gastric emptying after meals
These symptoms often improve as your body adjusts to the changes
Most clinical studies tracked fat loss for 48 weeks, with the most optimal effects at the end of treatment
If you have a product or nutrition question, or want to provide feedback, please reach out